Protective function of pirfenidone and everolimus on the development of chronic allograft rejection after experimental lung transplantation

MLA

Suesskind-Schwendi, M.von, et al. Protective Function of Pirfenidone and Everolimus on the Development of Chronic Allograft Rejection after Experimental Lung Transplantation. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....6de932c332464c4ff1bea068f6d86e95&authtype=sso&custid=ns315887.

APA

Suesskind-Schwendi, M. von, Heige, E. l, Pfaehler, S., Haneya, A., Schmid, C., Hirt, S. W., & Lehle, K. (2016). Protective function of pirfenidone and everolimus on the development of chronic allograft rejection after experimental lung transplantation.

Chicago

Suesskind-Schwendi, M. von, E. l Heige, S. Pfaehler, A. Haneya, C. Schmid, S.W. Hirt, and K. Lehle. 2016. “Protective Function of Pirfenidone and Everolimus on the Development of Chronic Allograft Rejection after Experimental Lung Transplantation,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....6de932c332464c4ff1bea068f6d86e95&authtype=sso&custid=ns315887.